Japan Blood Glucose Monitoring Market Insights Forecasts to 2033

• The Japan Blood Glucose Monitoring Market Size was valued at USD 0.84 Billion in 2023.
• The Market Size is Growing at a CAGR of 6.92% from 2023 to 2033
• The Japan Blood Glucose Monitoring Market Size is Expected to Reach USD 1.64 Billion by 2033.

The Japan Blood Glucose Monitoring Market Size is Anticipated to Reach USD 1.64 Billion by 2033, Growing at a CAGR of 6.92% from 2023 to 2033

Market Overview

Utilizing a glucose meter to measure the amount of glucose in the blood (glycemia) is known as blood glucose monitoring. A blood glucose test, which is especially crucial for managing diabetes, is usually carried out by putting blood into a disposable "test strip" that is chemically active after the skin is punctured (usually with a fingerstick). One of the most crucial parts of diabetes care is blood sugar monitoring, particularly for persons with type 1 diabetes and insulin users. Furthermore, more precise and user-friendly blood glucose devices have been developed in Japan as a result of technological improvements. For Japanese people with diabetes, these devices are more convenient and tempting because they frequently have features like wireless networking, smartphone integration, and continuous glucose monitoring. The market expansion has also been aided by the availability of such cutting-edge equipment in Japan

Report Coverage

This research report categorizes the market for the Japan blood glucose monitoring market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan blood glucose monitoring market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan blood glucose monitoring market.

Driving Factors

The rising incidence of diabetes and the growing number of older people in Japan who are at risk for diseases like diabetes are the main factors driving the market. Furthermore, the launch of new products into the Japanese market and growing awareness of diabetes prevention strategies are driving market expansion in Japan. According to a 2019 estimate by Japan's Ministry of Health, Labor, and Welfare, 11 million individuals in Japan are affected by diabetes, with an overall prevalence of 10.8% in women and 19.7% in men. One of the main factors driving the growth of the blood glucose monitoring market in Japan is the rising prevalence of diabetes, which is also boosting the use of blood glucose monitoring devices. Additionally, the Japanese government has been aggressively supporting programs for diabetes prevention and management, which has helped the market expand. The significance of routine blood glucose monitoring is frequently emphasized in these initiatives, which raises awareness and increases demand for blood glucose instruments.

Restraining Factors

The cost of blood glucose monitoring equipment is increasing due to the continuous technological developments in these devices, particularly in CGM systems.

Market Segmentation

The Japan blood glucose monitoring market share is classified into product and application.

• The self-monitoring segment is expected to hold a significant market share through the forecast period.

The Japan blood glucose monitoring market is segmented by product into self-monitoring and continuous glucose monitoring. Among these, the self-monitoring segment is expected to hold a significant market share through the forecast period. Its affordability and simplicity of usage are responsible for this. SMBG is seen to be an essential part of routine diabetic treatment. Using a glucose meter to check one's blood sugar levels is known as self-monitoring.

• The hospital segment is expected to dominate the Japan blood glucose monitoring market during the forecast period.       

Based on the application, the Japan blood glucose monitoring market is divided into hospital, clinics, and diagnostic centres. Among these, the hospital segment is expected to dominate the Japan blood glucose monitoring market during the forecast period. BGM devices are becoming more and more common in both inpatient and outpatient hospital settings due to the fact that they increase patients' quality of life and give practitioners precise data in a couple of seconds. Additional systems are in place in hospitals to store and transfer patient data.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan blood glucose monitoring market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Roche Holding AG
• Abbott Diabetes Care
• Medtronic PLC
• Dexcom Inc
• LifeScan
• Arkray
• Terumo Corporation
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In February 2022, the Japanese company Arkray, which creates equipment for urinalysis and diabetes testing, has started a corporate venture capital (CVC) company through a Singaporean partner.

Market Segment

This study forecasts revenue at Japan, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Japan Blood Glucose Monitoring Market based on the below-mentioned segments:

Japan Blood Glucose Monitoring Market, By Product

• Self-Monitoring
• Continuous Glucose Monitoring

Japan Blood Glucose Monitoring Market, By Application

• Hospital
• Clinics
• Diagnostic Centres